Behzad Aghazadeh, 10% Owner at Mirati Therapeutics, Inc. (MRTX), sold 62,500 shares at $101.88 ($6.4M) on 2019-07-23, disclosed to the SEC on 2019-07-25.
Open-market sale of $6.4M MRTX by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| Filing → |
| IMMU | BUY | 2019-12-09 | $35.0M | — | Filing → |
| MRTX | SELL | 2019-03-20 | $27.7M | — | Filing → |
| MRTX | SELL | 2019-02-21 | $50.1M | — | Filing → |